Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT-AF: Rivaroxaban and Ticagrelor in AF Patients Undergoing PCI
NCT02334254Phase 4Unknown
- Sponsor
- Beijing An Zhen Hospital
- Start
- Aug 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in Atrial fibrillation (AFib), coronary artery disease (CAD), sponsored by Beijing An Zhen Hospital. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02334254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334254.